Google AI ModeOct 7, 2026
Data as of Oct 8, 2026Based on 295 AI responses from ChatGPT Search and Google AI Mode
Reviewed by Dimitry Apollonsky ·
Many contract manufacturing organizations provide lyophilization services for injectable drug products. These providers offer varying levels of support, including formulation development, cycle optimization, and automated, sterile vial filling for both clinical trials and commercial-scale production. Popular options frequently cited for these capabilities include HTD Biosystems, Coriolis Pharma, Jubilant HollisterStier, and Vetter Pharma, among others.
Brands AI recommends here
Mentioned inRecommended in · Sep 7 – Oct 7, 2026
Google AI ModeOct 7, 2026
ChatGPT SearchOct 7, 2026
ChatGPT SearchSep 19, 2026
Google AI ModeSep 19, 2026
Google AI ModeSep 15, 2026
ChatGPT SearchSep 15, 2026
Google AI ModeSep 11, 2026
ChatGPT SearchSep 11, 2026
ChatGPT SearchSep 7, 2026
Google AI ModeSep 7, 2026
100% of citations to these sources link to brands' own websites.
lyotechnology.com
htdcorp.com
jublhs.com
cordenpharma.com
vetter-pharma.com
pharmacompass.com
argonautms.com
affinitylifesciences.com
pci.com
coriolis-pharma.com
A number of specialized Contract Development and Manufacturing Organizations (CDMOs) provide comprehensive lyophilization (freeze-drying) services for sterile injectable and parenteral drug products . These organizations handle everything from early-stage cycle development and formulation to clinical and commercial-scale aseptic manufacturing.
Prominent industry leaders offering these capabilities include:
If you're looking for a partner, let me know:
I can help narrow down which providers fit your project scope.
Yes. A number of CDMOs provide lyophilization (freeze-drying) as part of sterile injectable drug-product manufacturing, typically combining formulation/cycle development, aseptic fill-finish, lyophilization, inspection, packaging, and sometimes analytical/stability support.
| Provider | Lyophilization / injectable capability | Particularly relevant for |
|---|---|---|
| Thermo Fisher Scientific | Lyophilized vials from clinical through commercial scale; 130M+ sterile liquid/lyophilized vials annually | Large-scale commercial programs, biologics & small molecules |
| Pfizer CentreOne | Integrated lyophilization and sterile fill-finish; cycle development and validation | Complex injectables, biologics, ADCs, vaccines, small molecules |
| Recipharm | Dedicated sterile lyophilization, cycle optimization and scale-up to commercial production | Broad range of sterile injectables; strong lyophilization focus |
| PCI Pharma Services | Sterile fill-finish + lyophilization; formulation and cycle development; new large-scale lyophilization line in Bedford, NH | Clinical-to-commercial injectable programs, biologics and complex formulations |
| Boehringer Ingelheim | Connected freeze dryers with aseptic filling; liquid and lyophilized vials; up to 110,000 units/batch | Biologics and clinical/commercial manufacturing |
| Samsung Biologics | Scalable lyophilization integrated into cGMP drug-product suites | Biologics and sterile injectables; clinical & commercial scale |
| Sharp | Isolator-based sterile filling plus lyophilization, formulation and analytical support | Small/mid-scale clinical and commercial injectables |
| ROIS Pharma | Sterile fill-finish with specialized cytotoxic lyophilization and ADC capabilities | Highly potent/cytotoxic injectables and ADCs |
| Sophia CDMO | Formulation, thermal characterization, cycle development, aseptic fill-finish and lyophilized injectable manufacturing | Peptides, proteins, mAbs, vaccines, oncology and small molecules |
I'd put PCI, Thermo Fisher/Patheon, Sharp, Pfizer CentreOne, and ROIS high on the initial RFI/RFQ list. PCI is particularly interesting because its Bedford, New Hampshire operation has added a large-scale isolator fill-finish and lyophilization line.
For large commercial volumes, Thermo Fisher, Pfizer CentreOne, Recipharm, Samsung Biologics and Boehringer are worth evaluating. For smaller clinical batches or development work, Sharp and specialist CDMOs can be more flexible.
If you tell me (1) molecule type—small molecule, peptide, mAb/biologic, vaccine, etc., (2) vial size/fill volume, (3) clinical vs. commercial, and (4) approximate batch size, I can narrow this to 5–10 best-fit CDMOs and compare their lyophilizer capacity, location, injectable formats, GMP status, and development/commercial capabilities.
Yes. If you mean CDMOs/CMOs that can lyophilize sterile injectable drug products, there are quite a few established providers. Some offer the full pathway from formulation and cycle development through aseptic filling, lyophilization, packaging, and commercial manufacture.
| Provider | Lyophilization / injectable capabilities | Typical scope |
|---|---|---|
| patheon.com | Sterile fill-finish and lyophilized vials | Clinical through commercial; biologics & small molecules |
| pfizercentreone.com | Lyophilization, aseptic fill-finish | Biologics, small molecules, complex injectables |
| pci.com | Lyophilization cycle development, sterile fill-finish, bulk lyophilization | Clinical through commercial; biologics and sterile injectables |
| recipharm.com | Sterile lyophilization and vial filling | R&D cycle optimization through commercial production |
| sharpservices.com | Isolator-based sterile filling + lyophilization | Vials, syringes, cartridges; clinical through small/mid-scale commercial |
| biotechnique.com | Aseptic filling + optional lyophilization | Development through commercial |
| lyotechnology.com | Specialized lyophilization development and manufacturing | Injectable products, vials, syringes, cartridges, combination products |
| uip.pharmacy.uiowa.edu | Sterile injectable fill-finish + lyophilization | Clinical and commercial drug products |
| LYOCONTRACT GmbH | Aseptic fill-finish + lyophilization | Injectable vials; clinical through commercial |
For example, Thermo Fisher says its sterile network produces 130+ million sterile liquid and lyophilized vials annually, with lyophilized-vial formats from 2–100 mL. Patheon PCI specifically offers lyophilization cycle development, sterile fill-finish/lyophilization, and bulk lyophilization.
The best shortlist depends heavily on the product. In particular, I'd distinguish:
If you tell me the type of injectable (e.g., peptide, monoclonal antibody, small molecule), vial size, approximate batch size, and development stage, I can narrow this to 5–10 CDMOs that specifically fit the project, including facility location and whether they handle development, clinical, and commercial-scale lyophilization.
For example, Thermo Fisher says its sterile network produces 130+ million sterile liquid and lyophilized vials annually, with lyophilized-vial formats from 2–100 mL. PCI specifically offers lyophilization cycle development, sterile fill-finish/lyophilization, and bulk lyophilization.
A wide range of Contract Development and Manufacturing Organizations (CDMOs) specialize in aseptic fill-finish and lyophilization (freeze-drying) for injectable and parenteral drug products.
Leading providers servicing clinical through commercial-scale production include:
To explore directories or search by specific parameters like geographic region or clinical vs. commercial scale, you can browse listings on BioPharmGuy's Lyophilization Directory or review industry shortlists on platforms like Intuition Labs.
Could you share a bit more about your project so I can narrow this down? Specifically:
Contract Development and Manufacturing Organizations (CDMOs) provide specialized aseptic lyophilization (freeze-drying) services for sterile injectable drug products, biologics, and vaccines.
Major global providers with dedicated sterile fill-finish and freeze-drying infrastructure include:
If you'd like, let me know:
I can help narrow down the ideal CDMO partner for your specific molecule.
Lyophilization (freeze-drying) services for injectable drug products are typically provided by sterile fill-finish CDMOs (contract development and manufacturing organizations). These companies can support formulation development, cycle development/optimization, aseptic filling, lyophilization, inspection, packaging, and sometimes commercial manufacturing. Examples include:
| Provider | Lyophilization / injectable capabilities |
|---|---|
| Pfizer CentreOne | Lyophilized product development and manufacturing, including process optimization and scale-up for sterile injectable products. |
| AbbVie Contract Manufacturing | Lyophilization process optimization, technology transfer, and manufacture of lyophilized vials and other sterile presentations. |
| Sharp Services | Sterile injectable development/manufacturing, aseptic filling, and lyophilization services. |
| Samsung Biologics | CGMP aseptic fill-finish and scalable lyophilization for biologics and sterile injectables. |
| Fresenius Kabi Contract Manufacturing | Sterile pharmaceutical manufacturing with lyophilization, aseptic filling, formulation, and process optimization capabilities. |
| FAMAR | Lyophilized drug product manufacturing, vial aseptic filling, compounding, and sterilization services. |
| Ethypharm | Lyophilized sterile dosage forms, freeze-dried vials, prefilled syringes, and injectable products. |
| Biopharma Group | Contract freeze-drying services and lyophilization support. |
| Lyophilization Technology Inc. | Specialized lyophilization CDMO services covering injectable products, formulation, cycle design, characterization, and clinical manufacturing. |
| UI Pharmaceuticals | Sterile fill-finish, injectable manufacturing, and lyophilization for clinical and commercial drug products. |
| Pyramid Laboratories | Clinical and GMP lyophilization manufacturing, including freeze-dried drug products. |
| Sophia CDMO | Lyophilized injectable development and manufacturing support for biologics, peptides, proteins, vaccines, oncology products, and complex injectables. |
Key capabilities to look for when selecting a provider:
If you are looking for a US-based provider, EU-based provider, or a provider suitable for a specific product type (e.g., mAb, peptide, vaccine, ADC, or small molecule injectable), I can narrow the list.
Lyophilization (freeze-drying) for sterile injectable and biological drug products is provided by specialized Contract Development and Manufacturing Organizations (CDMOs) . These companies handle formulation development, thermal characterization, aseptic fill-finish, and commercial scale freeze-drying.
Prominent global providers offering lyophilization services for injectables include:
If you are looking for a partner, let me know:
Yes. Lyophilization (freeze-drying) of injectable drug products is commonly outsourced to CDMOs/CMOs that provide sterile fill-finish plus lyophilization. Some established providers include:
The right shortlist depends heavily on whether you need development-scale lyophilization, clinical GMP batches, or commercial manufacturing. I'd evaluate:
If you tell me the drug type (small molecule/biologic), vial size, approximate batch size, and whether you're at preclinical, clinical, or commercial stage, I can narrow this to 5–10 CDMOs that are particularly well suited, including their locations and relevant lyophilizer/fill-finish capabilities.
Yes. A number of CDMOs/CMOs provide GMP lyophilization (freeze-drying) for injectable drug products, usually bundled with formulation/process development, aseptic filling, stoppering, inspection, and packaging.
| Provider | Lyophilized injectable capability | Typical positioning |
|---|---|---|
| Catalent | Injectable process development, lyophilization, sterile fill-finish | Clinical through commercial; biologics and sterile injectables |
| Thermo Fisher Scientific | Lyophilization cycle optimization + aseptic fill-finish | Clinical/commercial parenterals; integrated development and manufacturing |
| PCI Pharma Services | Lyophilization cycle development, sterile fill-finish, bulk lyophilization | Strong specialist in lyophilization; clinical through commercial |
| Pfizer CentreOne | Aseptic lyophilization and liquid fill-finish | Complex sterile injectables, including biologics and small molecules; global network |
| AbbVie Contract Manufacturing | Lyophilized vial fill-finish, cycle optimization and scale-up | 2R–20R vials; clinical and commercial manufacturing |
| Sharp | Lyophilization + isolator-based sterile filling | Particularly attractive for clinical/small-to-mid-scale commercial programs |
| Pyramid Pharma Services | Clinical lyophilization + vial/syringe filling | Clinical drug products; freeze dryer capacity up to ~7,000 vials/batch |
| Samsung Biologics | Scalable lyophilization integrated with aseptic fill-finish | Biologics and sterile injectables; large-scale manufacturing |
| ProBio CDMO | Lyophilized and liquid injectable fill-finish | Pilot through commercial scale |
A recent industry comparison also identifies Lonza, Simtra BioPharma Solutions, Recipharm, Vetter Pharma, WuXi STA, Piramal Pharma Solutions, and Curia among the leading lyophilization CDMOs.
The most important distinction is what kind of lyophilization service you need:
For example, PCI specifically describes both lyophilization cycle development and large-scale sterile fill-finish/lyophilization, while Pfizer CentreOne emphasizes decades of aseptic lyophilization for complex sterile injectables.
If you tell me (1) molecule type—small molecule, peptide, mAb/biologic, vaccine, etc., (2) vial/syringe format, (3) clinical vs. commercial, and (4) approximate batch size, I can narrow this to 5–10 best-fit CDMOs, including their locations, lyophilizer capacities, vial sizes, regulatory status, and whether they accept early-stage projects.
The most important distinction is what kind of lyophilization service you need:
Numerous Contract Development and Manufacturing Organizations (CDMOs) specialize in aseptic fill-finish and lyophilization (freeze-drying) for sterile injectable and parenteral drug products.
Leading providers servicing clinical through commercial-scale production include:
For a broader directory of specialized niche or regional providers, you can explore specialized databases like BioPharmGuy's Lyophilization Directory or review market overviews on Intuition Labs.
If you can share whether your project is in clinical trials or commercial scale , and whether it is a small molecule or biologic , I can help narrow down which of these CDMOs best matches your technical requirements.